Optimind Pharma Corp.
OMND
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.20% | 32.69% | -27.82% | 175.36% | 210.17% |
| Total Receivables | -20.88% | -55.48% | 18.30% | -60.85% | -61.96% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.90% | -8.45% | -15.81% | -25.02% | -15.05% |
|
|
|||||
| Total Current Assets | -12.90% | -8.45% | -15.81% | -25.02% | -15.05% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -9.80% | -6.90% | -12.79% | -20.97% | -74.22% |
|
|
|||||
| Total Accounts Payable | 33.13% | 20.14% | -52.66% | -41.85% | 24.01% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -3.68% | -5.69% | -4.78% | -5.94% | -78.68% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.41% | 7.63% | -39.95% | -29.60% | -62.64% |
|
|
|||||
| Total Current Liabilities | 15.41% | 7.63% | -39.95% | -29.60% | -62.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -3.68% | -5.69% | -4.78% | -5.94% | -78.68% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.41% | 9.51% | -39.95% | -29.60% | -63.12% |
|
|
|||||
| Common Stock & APIC | 0.41% | -1.65% | 5.22% | -0.35% | 14.31% |
| Retained Earnings | -1.61% | 0.85% | -1.57% | 1.74% | -17.94% |
| Treasury Stock & Other | 0.26% | -1.75% | -0.76% | -6.02% | -3.17% |
| Total Common Equity | -126.45% | -101.03% | 69.64% | 45.43% | -140.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -126.45% | -101.03% | 69.64% | 45.43% | -140.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -126.45% | -101.03% | 69.64% | 45.43% | -140.76% |
|
|
|||||